<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://mtimes.net/article/1360</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T01:36:50.322Z</news:publication_date>
      <news:title>HanAll Biopharma Eyes 2028 Launch for Graves&apos; Disease Treatment IMVT-1402, Backed by Global Partner Immunovant</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/article/982</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T01:36:50.322Z</news:publication_date>
      <news:title>KOSDAQ and the era of bio hardship, a market whose goal is to recover to 1,000</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/article/952</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T01:36:50.322Z</news:publication_date>
      <news:title>[Big Insight-Mer] Why Entropic CEO mentioned AI speed control (feat Hugging Face Incident)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/article/918</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T01:36:50.322Z</news:publication_date>
      <news:title>[K-Bio FDA approval strategy] “Clinical trials alone are not enough”… Recommendations from a former FDA reviewer</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/article/872</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T01:36:50.322Z</news:publication_date>
      <news:title>[Planning] ALT-B4 opened with Keytruda… Alteogen, expansion begins now</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/article/773</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T01:36:50.322Z</news:publication_date>
      <news:title>Semiconductor, Hanmi Pharmaceutical, and K Bio</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/article/758</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T01:36:50.322Z</news:publication_date>
      <news:title>[Planning] Merger of par value 23 times, listed company goes to court… Changed landscape after ‘KOSDAQ delisting rule’</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/article/625</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T01:36:50.322Z</news:publication_date>
      <news:title>[Exclusive] Will the application of Alteogen ALT-B4 be expanded to include Keytruda? Merck/Kelloun patent captured 2</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/article/615</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T01:36:50.322Z</news:publication_date>
      <news:title>[Exclusive] Will the application of Alteogen ALT-B4 be expanded to include Keytruda? Merck/Kelun patent captured 1</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/article/583</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T01:36:50.322Z</news:publication_date>
      <news:title>[Exclusive] HLB Dong-ho Dong’s ‘controversy over cancellation of bulk market price selling orders’… Suspicion of short selling market manipulation increases</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/article/1582</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T01:36:50.322Z</news:publication_date>
      <news:title>Fed Warns of Hidden Risks in Big Tech AI Investment Surge</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/article/1541</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T01:36:50.322Z</news:publication_date>
      <news:title>KOSPI Earnings Outlook: Semiconductor Boom Masks Widespread Sector Decline</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/article/1518</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T01:36:50.322Z</news:publication_date>
      <news:title>US CPI Surpasses Expectations, Fueling Treasury Yields and December Tightening Concerns</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/article/1517</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T01:36:50.322Z</news:publication_date>
      <news:title>Bank of Japan Faces Dilemma as Weak Consumption and Market Volatility Complicate Rate Hike Path</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/article/1580</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-15T23:27:49.684Z</news:publication_date>
      <news:title>Alteogen Targets Monthly Obesity Injections, Outperforming Eli Lilly’s Retatrutide in Animal Studies</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/article/1578</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-15T04:01:24.825Z</news:publication_date>
      <news:title>[Renewable Energy Planning 1] Renewable energy receiving attention again due to the U.S. Blue Wave... Korea’s opportunity</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/article/1575</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T07:39:02.746Z</news:publication_date>
      <news:title>K-Bio at a Crossroads: AriBio and HLB Therapeutics Await Pivotal Phase 3 Results</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/article/1574</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T06:33:27.550Z</news:publication_date>
      <news:title>GC Genome Expects Sixth Straight Quarter of Operating Profit Driven by US Pancreatic Cancer Diagnostic Push</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/ja/article/1360</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T01:36:50.322Z</news:publication_date>
      <news:title>[Kバイオグローバル三相|企画7] ハンオールバイオパーマ「アイメロフルバート、2028年グレーブス病治療剤発売目標」</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/ja/article/982</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T01:36:50.322Z</news:publication_date>
      <news:title>コスダックとバイオ受難の時代1000回復が目指した市場</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/ja/article/952</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T01:36:50.322Z</news:publication_date>
      <news:title>[ビッグインサイト - メール]エントロピックCEOがAIスピード調整を言及した理由（featハギングフェイス事件）</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/ja/article/918</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T01:36:50.322Z</news:publication_date>
      <news:title>[K-バイオFDA許可戦略] 「臨床だけではいけない」…元FDA審査官の提言</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/ja/article/872</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T01:36:50.322Z</news:publication_date>
      <news:title>[企画]キトルダでドアを開けたALT-B4…アルテオゼン、拡張はこれから</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/ja/article/773</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T01:36:50.322Z</news:publication_date>
      <news:title>半導体と韓米医薬品とKバイオ</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/ja/article/758</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T01:36:50.322Z</news:publication_date>
      <news:title>【企画】額面併合23倍、上場社は裁判所に… 「コスダック上廃ルール」以降変わった風景</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/ja/article/625</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T01:36:50.322Z</news:publication_date>
      <news:title>[単独]アルテオジェンALT-B4、キトルダ他適用拡大されるが…メルク・ケルン特許書捕捉 2</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/ja/article/615</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T01:36:50.322Z</news:publication_date>
      <news:title>[単独]アルテオジェンALT-B4、キトルダ他適用拡大されるが…メルク・ケルン特許書捕獲 1</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/ja/article/583</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T01:36:50.322Z</news:publication_date>
      <news:title>[単独] HLB同時号が「大量市場家売り注文取り消し論議」…販売も相場操縦疑惑に加わる</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/ja/article/1582</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T01:36:50.322Z</news:publication_date>
      <news:title>AI投資を支える負債と保証、米連邦準備制度理事会がビッグテックの負担に警鐘</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/ja/article/1541</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T01:36:50.322Z</news:publication_date>
      <news:title>KOSPIの来期営業益は44%増予想も、26業種中19業種で下方修正</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/ja/article/1518</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T01:36:50.322Z</news:publication_date>
      <news:title>米CPIが予想を上回る、国債利回り上昇で12月の金融引き締め警戒感が高まる</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/ja/article/1517</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T01:36:50.322Z</news:publication_date>
      <news:title>日銀の利上げにジレンマ、物価上昇の一方で個人消費の急減と株安が重石に</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/ja/article/1580</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:publication_date>2026-11-15T23:27:49.684Z</news:publication_date>
      <news:title>アルテオジェン、月1回投与の肥満症治療薬に挑戦 米イーライリリーの次世代薬を上回る減量効果を確認</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/ja/article/1578</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:publication_date>2026-11-15T04:01:24.825Z</news:publication_date>
      <news:title>[新再生可能エネルギー企画1]米ブルーウェーブに再び注目される新再生可能エネルギー…韓国のチャンスは</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/ja/article/1575</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T07:39:02.746Z</news:publication_date>
      <news:title>Kバイオ運命の1週間…アリバイオとHLBセラピューティクスの第3相試験結果に注目</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/ja/article/1574</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T06:33:27.550Z</news:publication_date>
      <news:title>GCゲノム、6四半期連続の黒字達成に期待…米国での膵臓がん診断で勝負</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/zh/article/1360</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>zh-cn</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T01:36:50.322Z</news:publication_date>
      <news:title>[K Bio Global 3 期 | 【计划7】Hanall Biopharma“Imeropruvat，目标2028年推出格雷夫斯病治疗”</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/zh/article/982</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>zh-cn</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T01:36:50.322Z</news:publication_date>
      <news:title>科斯达克和生物困难时代，目标是恢复到 1,000 的市场</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/zh/article/952</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>zh-cn</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T01:36:50.322Z</news:publication_date>
      <news:title>【大洞察-Mer】Entropic CEO为何提到AI速度控制（壮举抱脸事件）</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/zh/article/918</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>zh-cn</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T01:36:50.322Z</news:publication_date>
      <news:title>【K-Bio FDA 审批策略】“仅靠临床试验是不够的”……前 FDA 审查员的建议</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/zh/article/872</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>zh-cn</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T01:36:50.322Z</news:publication_date>
      <news:title>[计划] ALT-B4 与 Keytruda 一起开业……Alteogen，扩张现在开始</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/zh/article/773</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>zh-cn</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T01:36:50.322Z</news:publication_date>
      <news:title>半导体、韩美制药、K Bio</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/zh/article/758</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>zh-cn</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T01:36:50.322Z</news:publication_date>
      <news:title>【策划】面值合并23次，上市公司告上法庭……“科斯达克退市规则”后格局变了</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/zh/article/625</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>zh-cn</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T01:36:50.322Z</news:publication_date>
      <news:title>【独家】Alteogen ALT-B4的应用是否会扩大到Keytruda？获得 Merck/Kelloun 专利 2</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/zh/article/615</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>zh-cn</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T01:36:50.322Z</news:publication_date>
      <news:title>【独家】Alteogen ALT-B4的应用是否会扩大到Keytruda？获得默克/科伦专利 1</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/zh/article/583</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>zh-cn</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T01:36:50.322Z</news:publication_date>
      <news:title>[独家]HLB东浩董“取消大宗市价卖单争议”……卖空市场操纵嫌疑增加</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/zh/article/1582</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>zh-cn</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T01:36:50.322Z</news:publication_date>
      <news:title>AI投资背后的债务与担保风险：美联储警示大型科技公司财务压力</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/zh/article/1541</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>zh-cn</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T01:36:50.322Z</news:publication_date>
      <news:title>KOSPI明年盈利预期增长44%，但26个行业中有19个出现下滑</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/zh/article/1518</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>zh-cn</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T01:36:50.322Z</news:publication_date>
      <news:title>美国10月CPI超预期，国债收益率上升加剧12月紧缩警惕</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/zh/article/1517</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>zh-cn</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T01:36:50.322Z</news:publication_date>
      <news:title>日本央行陷入加息困境：通胀压力与股市动荡并存</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/zh/article/1580</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>zh-cn</news:language>
      </news:publication>
      <news:publication_date>2026-11-15T23:27:49.684Z</news:publication_date>
      <news:title>Alteogen挑战月度减肥针：动物实验减重效果优于礼来新药</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/zh/article/1578</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>zh-cn</news:language>
      </news:publication>
      <news:publication_date>2026-11-15T04:01:24.825Z</news:publication_date>
      <news:title>[可再生能源规划1]可再生能源因美国蓝潮再次受到关注...韩国的机会</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/zh/article/1575</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>zh-cn</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T07:39:02.746Z</news:publication_date>
      <news:title>韩国生物医药的关键一周：AriBio与HLB Therapeutics临床三期结果备受瞩目</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mtimes.net/zh/article/1574</loc>
    <news:news>
      <news:publication>
        <news:name>MTIMES Global</news:name>
        <news:language>zh-cn</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T06:33:27.550Z</news:publication_date>
      <news:title>GC Genome有望连续6个季度实现盈利，全力进军美国胰腺癌诊断市场</news:title>
    </news:news>
  </url>
</urlset>